Summary
Progressive capillary occlusion often leads to severe retinopathy within 15–20 years of the onset of Type 1 (insulin-dependent) diabetes mellitus. Lipoprotein (a), a complex formed by apolipoprotein (a), apo B-100 and lipids, is considered an independent, genetically determined, predictor of cardiovascular disease. It may have antifibrinolytic properties in view of its similarity to plasminogen. To test the hypothesis that circulating lipoprotein (a) is associated with the process that leads to clinically active diabetic retinopathy, we measured the circulating levels of apolipoprotein (a) (which are strictly correlated with those of lipoprotein (a)) in two groups of patients with Type 1 diabetes of at least 15 years duration: 25 with active retinopathy and 27 without clinically detectable retinal lesions. Thirty-eight healthy subjects of the same age and sex served as controls. Serum apolipoprotein (a) was higher in the patients with active retinopathy (36(2-193) U/dl, geometric mean and range) than in those without clinically detectable retinal lesion (17(1–160)) and the control subjects (14(0–115)), p < 0.01 in both cases. The distribution of apolipoprotein (a) levels was skewed to the left, as expected, in the patients without clinically evident retinal lesions and the control groups, but there was a bimodal trend of distribution among those with active retinopathy. The levels of glycated haemoglobin were similar in the two groups of diabetic patients, and no significant differences were found for total and HDL cholesterol, triglycerides or apolipoproteins A1 and B between them and the control subjects. These preliminary results suggest that serum apolipoprotein (a) is elevated in patients with active retinopathy. The role of this lipoprotein as a predictor or a pathogenic effector of diabetic retinopathy, or both deserves further investigation.
Article PDF
Similar content being viewed by others
References
Klein R, Klein BEK, Moss SE (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 527–532
Kohner EM, Porta M (1990) Diabetic retinopathy. In: Alberti KGMM, Krall LP (eds) The diabetes annual. Vol. 5. Elsevier, Amsterdam, pp 273–300
Barbosa J, Saner B (1984) Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia 27: 487–492
Uterman G (1989) The mysteries of lipoprotein (a). Science 246: 904–910
Haffner SM, Turtle KR, Rainwater DL (1981) Decrease of lipoprotein (a) with improved glycaemic control in IDDM subjects. Diabetes Care 14: 302–307
Scott J (1989) Thrombogenesis is linked to atherogenesis at last? Nature 341: 22–23
Muls E, Blaton V, Rosseneu M, Lesaffre E, Lamberigts G, De Moor P (1982) Serum lipids and apolipoprotein A1, A2 and B in hyperthyroidism before and after treatment. J Clin Endocrin Metab 55: 459–464
Jenkins AJ, Steele JS, Janus ED, Best JD (1991) Increased plasma apolipoprotein (a) levels in IDDM patients with microalbuminuria. Diabetes 40: 787–790
Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30: 144–148
Maioli M, Tonolo G, Arca GM et al. (1992) Lipid pattern and apolipoprotein A1 and B and lipoprotein (a) in insulin dependent diabetic patients with microalbuminuria. Acta Diabetologica (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maioli, M., Tonolo, G., Pacifico, A. et al. Raised serum apolipoprotein (a) in active diabetic retinopathy. Diabetologia 36, 88–90 (1993). https://doi.org/10.1007/BF00399100
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00399100